Prognostic value of MTA1, SOX4 and EZH2 expression in esophageal squamous cell carcinoma

xlomafota13 shared this article with you from Inoreader Prognostic value of MTA1, SOX4 and EZH2 expression in esophageal squamous cell carcinoma Via Experimental and therapeutic medicine Exp Ther Med. 2021 Jul;22(1):722. doi: 10.3892/etm.2021.10154. Epub 2021 May 3. ABSTRACT Esophageal cancer has always been one of the major malignant tumor types affecting the health of the Chinese population. Metastasis-associated protein 1 (MTA1), SOX4 and enhancer of zeste homolog 2 (EZH2) are all potent inducers of invasion and metastasis in esophageal squamous cell carcinoma (ESCC). However, the role of these signaling molecules and their implication in ESCC have remained largely elusive. In the present study, the effects of MTA1, SOX4 and EZH2 on the prognosis of patients with ESCC were explored. Immunohistochemistry was used to examine the expression levels of MTA1, SOX4 and EZH2. The χ2 test was used to analyze the association between protein expression and clinicopathological parameters. Kaplan-Meier curves and Cox proportional hazards model survival analysis was performed to investigate the effects of the three pr oteins examined on disease prognosis. The results indicated that MTA1 may be used as a prognostic and diagnostic marker for ESCC. To the best of our knowledge, the present study was the first to demonstrate that MTA1-SOX4 signaling is associated with prognosis in ESCC. However, no significant association was noted between SOX4 and EZH2 in the present study, which was inconsistent with previously reported findings. The function of the MTA1-SOX4-EZH2 axis and the interactions of the proteins involved require further investigation. PMID:34007331 | PMC:PMC8120658 | DOI:10.3892/etm.2021.10154 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.